Artivion (AORT) Cash & Current Investments (2010 - 2026)
Artivion (AORT) posted Cash & Current Investments of $55.8 million for Q1 2026, down 14.09% on a QoQ basis from $64.9 million in Q4 2025, and up 47.94% year-over-year from $37.7 million in Q1 2025.
Artivion (AORT) Cash & Current Investments (2010 - 2026) Analysis & Trends
Artivion's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $55.8 million for Q1 2026.
- Quarterly Cash & Current Investments rose 47.94% year-over-year to $55.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.8 million (up 47.94% YoY) and the FY2025 annual result came in at $64.9 million, up 21.41% from the prior year.
- Cash & Current Investments was $55.8 million for Q1 2026 at Artivion, down from $64.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $73.4 million in Q3 2025 and bottomed at $10.0 million in Q2 2022.
- A 5-year average of $48.9 million and a median of $53.5 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments sank 80.35% — and 2023, when it soared 386.53%.
- Artivion's Cash & Current Investments stood at $39.4 million in 2022, then surged by 49.78% to $58.9 million in 2023, then decreased by 9.29% to $53.5 million in 2024, then advanced by 21.41% to $64.9 million in 2025, then slipped by 14.09% to $55.8 million in 2026.
- Business Quant data shows AORT's Cash & Current Investments at $55.8 million in Q1 2026, $64.9 million in Q4 2025, and $73.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn | 1.12 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Artivion | 1.25 Bn | 1.20 Bn | 75.45 Mn | 55.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.76 Mn |
| Dec 31, 2025 | 64.91 Mn |
| Sep 30, 2025 | 73.43 Mn |
| Jun 30, 2025 | 53.48 Mn |
| Mar 31, 2025 | 37.69 Mn |
| Dec 31, 2024 | 53.46 Mn |
| Sep 30, 2024 | 56.17 Mn |
| Jun 30, 2024 | 55.02 Mn |
| Mar 31, 2024 | 51.12 Mn |
| Dec 31, 2023 | 58.94 Mn |
| Sep 30, 2023 | 53.48 Mn |
| Jun 30, 2023 | 48.78 Mn |
| Mar 31, 2023 | 30.77 Mn |
| Dec 31, 2022 | 39.35 Mn |
| Sep 30, 2022 | 37.57 Mn |
| Jun 30, 2022 | 10.03 Mn |
| Mar 31, 2022 | 51.41 Mn |
| Dec 31, 2021 | 55.01 Mn |
| Sep 30, 2021 | 65.13 Mn |
| Jun 30, 2021 | 51.03 Mn |